BRDT is aberrantly expressed in over 30% of ESCC, enhances ΔNp63 (a defining factor of the squamous subtype)-dependent SE-associated genes, and controls the migratory potential of ESCC cells (Wang et al., 2021b). Here, BRDT is linked to esophageal squamous cell carcinoma.